UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 20 von 174
Datensatz exportieren als...
BibTeX
Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease
Movement disorders, 2007-05, Vol.22 (7), p.990-997
Piboolnurak, Panida
Lang, Anthony E.
Lozano, Andres M.
Miyasaki, Janis M.
Saint-Cyr, Jean A.
Poon, Yu-Yan W.
Hutchison, William D.
Dostrovsky, Jonathan O.
Moro, Elena
2007
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Piboolnurak, Panida
Lang, Anthony E.
Lozano, Andres M.
Miyasaki, Janis M.
Saint-Cyr, Jean A.
Poon, Yu-Yan W.
Hutchison, William D.
Dostrovsky, Jonathan O.
Moro, Elena
Titel
Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease
Ist Teil von
Movement disorders, 2007-05, Vol.22 (7), p.990-997
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2007
Quelle
MEDLINE
Beschreibungen/Notizen
Subthalamic nucleus deep brain stimulation (STN‐DBS) is effective in advanced Parkinson's disease (PD), but its effects on the levodopa response are unclear. We studied the levodopa response after long‐term STN‐DBS, STN‐DBS efficacy and predictive value of preoperative levodopa response to long‐term DBS benefit in 33 PD patients with bilateral STN‐DBS. Patients were assessed using the Unified Parkinson's Disease Rating Scale preoperatively (with and without medications) and postoperatively (without medications or stimulation, with only medications or stimulation, and with both medications and stimulation). Levodopa response significantly decreased postoperatively by 31.1% at 3 years and 32.3% at 5 years, possibly related to the reduction in medication requirement, direct STN stimulation effect or PD progression. STN‐DBS alone significantly improved motor scores (37.2% at 3 years and 35.1% at 5 years) and activities of daily living scores (27.1% at 3 years and 19.2% at 5 years). Anti‐PD drugs were significantly reduced by 47.9% at 3 years and 39.8% at 5 years. However, the magnitude of the preoperative response to levodopa did not predict DBS benefit at 3 and 5 years. © 2007 Movement Disorder Society
Sprache
Englisch
Identifikatoren
ISSN: 0885-3185
eISSN: 1531-8257
DOI: 10.1002/mds.21482
Titel-ID: cdi_proquest_miscellaneous_70562507
Format
–
Schlagworte
Antiparkinson Agents - therapeutic use
,
Biological and medical sciences
,
deep brain stimulation
,
Deep Brain Stimulation - methods
,
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
,
Drug toxicity and drugs side effects treatment
,
Female
,
Follow-Up Studies
,
Humans
,
Levodopa - therapeutic use
,
levodopa response
,
long-term benefit
,
Male
,
Medical sciences
,
Middle Aged
,
Neurology
,
Parkinson Disease - drug therapy
,
Parkinson Disease - pathology
,
Parkinson Disease - surgery
,
Parkinson's disease
,
Pharmacology. Drug treatments
,
Retrospective Studies
,
Statistics, Nonparametric
,
subthalamic nucleus
,
Subthalamic Nucleus - surgery
,
Time Factors
,
Toxicity: nervous system and muscle
,
Treatment Outcome
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX